Comparison of the effect of gonadotropin-releasing hormone agonist dosage in girls with central precocious puberty
Purpose There are no definite guidelines on the optimal dosage of gonadotropin-releasing hormone (GnRH) agonist for treatment of central precocious puberty (CPP). We compared growth outcomes of GnRH agonist at different dosages in girls with idiopathic CPP to assess the optimal dosage. Methods This...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Korean Society of Pediatric Endocrinology
2023-02-01
|
| Rangatū: | Annals of Pediatric Endocrinology & Metabolism |
| Ngā marau: | |
| Urunga tuihono: | http://e-apem.org/upload/pdf/apem-2244210-105.pdf |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|